Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

8.780 +0.060 (+0.69%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,065,611
Open 8.410
Bid (Size) 8.340 (1)
Ask (Size) 9.050 (3)
Prev. Close 8.720
Today's Range 8.270 - 9.140
52wk Range 8.690 - 19.11
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including NeoGenomics (NASDAQ:NEO) and its peers. 
Via StockStory
Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics
From NeoGenomics, Inc.
Via Business Wire

Performance

YTD
-46.8%
-46.8%
1 Month
-6.0%
-6.0%
3 Month
-46.8%
-46.8%
6 Month
-37.8%
-37.8%
1 Year
-41.0%
-41.0%

More News

Read More
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
Via StockStory
Demystifying NeoGenomics: Insights From 6 Analyst Reviews
Via Benzinga
5 Analysts Assess NeoGenomics: What You Need To Know
Via Benzinga
Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses
Via StockStory
3 Reasons to Sell NEO and 1 Stock to Buy Instead
Via StockStory
NeoGenomics Appoints Warren Stone as President & Chief Operating Officer
From NeoGenomics, Inc.
Via Business Wire
Earnings Scheduled For March 18, 2025
Via Benzinga
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
Via StockStory
3 Small-Cap Stocks in Hot Water
Via StockStory
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
From NeoGenomics, Inc.
Via Business Wire
3 Healthcare Stocks Skating on Thin Ice
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
What To Expect From RadNet’s (RDNT) Q4 Earnings
Via StockStory
NeoGenomics to Participate in Upcoming Investor Conferences
From NeoGenomics, Inc.
Via Business Wire
Why NeoGenomics (NEO) Shares Are Trading Lower Today
Via StockStory
NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets
Via StockStory
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
From NeoGenomics, Inc.
Via Business Wire
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Earnings Scheduled For February 18, 2025
Via Benzinga
NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance
Via Investor's Business Daily
NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
From NeoGenomics, Inc.
Via Business Wire
Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
From Adaptive Biotechnologies
Via GlobeNewswire

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 8.780
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 04/04/25 04:00 PM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 1.08B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.